High Doses Of Common Chemo Drug Methotrexate Limit Relapses Of Childhood Leukemia
- OPACC
- Apr 27, 2016
- 1 min read
With a cure rate approaching 90 percent, acute lymphoblastic leukemia (ALL), the most common type of childhood cancer, is one of the big "success stories" of modern cancer treatment. Yet up to 20 percent of patients with a high risk of relapse are not cured, which could change with the results from a clinical trial showing that high doses of the commonly-used chemotherapy drug methotrexate increases the survival rate for these patients.
Recent Posts
See AllThe FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...